SEC Comment Letter for BOSTON SCIENTIFIC CORP (BSX) (CIK 0000885725) (BSX) — Jul 25, 2013
BOSTON SCIENTIFIC CORP (BSX) (CIK 0000885725)
Date: July 25, 2013 · CIK: 0000885725 · Accession: 0000000000-13-040898
AI Filing Summary & Sentiment
Show Raw Text
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
DIVISION OF
CORPORATION FINANCE
July 25 , 2013
Via E -mail
Mr. Jeffrey Capello
Executive Vice President and Chief Financial Officer
Boston Scientific Corporation
One Boston Scientific Place
Natick, Massachusetts 01760 -1537
Re: Boston Scientific Corporation
Form 10 -K for the Fiscal Year Ended December 31, 2012
Filed February 22, 2013
File No. 001 -11083
Dear Mr. Capello:
We have completed our review of your filings. We remind you that our comments or
changes to disclosure in response to our comments do not foreclose the Commission from
taking any action with respect to the company or the filing s and the company may not as sert
staff comments as a defense in any proceeding initiated by the Commission or any person
under the federal securities laws of the United States. We urge all persons who are responsible
for the accuracy and adequacy of the disclosure in the filing s to be certain that the filing s
include the information the Securities Exchange Act of 1934 and all applicable rules require.
Sincerely,
/s/Brian Casio
Brian R. Cascio
Accounting Branch Chief